Abstract:The purpose of the present study was to prepare a clonidine hydrochloride (CH) sustained-release suspension.The processes involved in the drug formulation included drug loading, impregnating, and suspension preparation. Clonidine hydrochloride drug–resin complexes (CH-DRC) were prepared using the bath method and the CH-DRC impregnated before the microencapsulation process. Based on the bottom spray fluidized bed coating method, the CH microencapsulated drug–resin complexes (CH-MC) were also prepared using Surelease® (the suspension of ethyl cellulose aqueous dispersion) as the coating material. The effects of coating (process/formulation) on the in vitro release of coating microcapsule were evaluated via single factor investigation and orthogonal design optimization. The CH-MC with optimized formulation was further dispersed in a suitable medium to obtain a sustained-release suspension. Rats were given commercial CH ordinary tablets and the CH sustained-release suspension via intragastric administration. The plasma concentration–time curve and related pharmacokinetic parameters were investigated using the non-compartment model.The Tmax of the CH sustained-release suspension was delayed from 2 h to 5 h compared with the CH ordinary tablets. Similarly, the Cmax was reduced from 32.138 µg·mL−1 to 18.150 µg·mL−1 with the concentration–time curve being more gentle compared with the commercially CH ordinary tablets. After oral administration, the relative bioavailability of CH sustained-release suspension (AUC0–24 of 137.703 µg·h·mL−1) to its CH ordinary tablets (AUC0–24 of 123.337 µg·h·mL−1) was 111.65%.The findings showed that the CH sustained-release suspension for oral administration was successfully formulated.

Preparation and Release of Potassium Citrate Sustained-Release Tablets

Study on pramipexole dihydrochloride sustained-release tablets

Preparation of Captopril Delayed-Onset, Sustained Release Tablets

Study on Correlation Between in vitro Release and in vivo Absorption of Captopril Delayed-onset, Sustained Release Tablet

Delayed Sustained Drug Release from Electrostatic Powder Coated Tablets with Ultrafine Polymer Blends

Study on Correlation Between {\sl in Vitro} Release and {\sl in Vivo} Absorption of Captopril Delayed--onset, Sustained Release Tablet

Preparation of Sustained Release Capsules by Electrostatic Dry Powder Coating, Using Traditional Dip Coating As Reference

Optimal formulation and technology of captopril sustained-release tablet

Preparation and in Vitro Release Study of Sodium Ferulate Gastric Floating Tablets

Studies on controlled release effervescent osmotic pump tablets from Traditional Chinese Medicine Compound Recipe

Studies on Preparation and in vitro Drug Release of Sodium Ferulate Double-layer Tablets

Preparation of Compound Sodium Ferulate-gastrodin Quick-release Double-layer Tablets

Preparation and in vitro/in vivo evaluation of a clonidine hydrochloride drug–resin suspension as a sustained-release formulation

Study on Preparation of Konjac Glucomannan- Hydroxypropyl Methyl Cellulose Compression Coated Tablets for Colonic Delivery and in Vitro Release

In Vitro Controlled Release of Sodium Ferulate from Compritol 888 ATO-based Matrix Tablets.

A comparative study of the effect of different alkaline stabilizers on physicochemical properties of lansoprazole in formulation

Towards a Better Understanding of the Post-Gastric Behavior of Enteric-Coated Formulations

Studies on Sustained Release Hydrophilic Matrix Tablets Containing Hydroxypropylmethylceilulose and Carbopol

Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results

Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride